By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kineta Inc. 

307 Westlake Ave North
Suite 200
Seattle  Washington  98109  U.S.A.
Phone: 206-378-0400 Fax: 206-378-0408



Start Up

Company News
Kineta To Give Update On Dalazatide Clinical Trial Results At BIO International Meeting 6/9/2015 12:09:37 PM
Kineta Expands Seattle Footprint With New Office Space 5/14/2015 6:13:25 AM
Kineta Inc. Announces Promising Top-Line Clinical Results For Dalazatide; Target Implicated In Broad Array Of Autoimmune Diseases 5/5/2015 8:56:46 AM
Kineta Inc., University of Groningen Present New, Positive Data For Dalazatide In ANCA Vasculitis, An Orphan Disease 4/21/2015 11:41:05 AM
Kineta Inc.’s Adjuvants Boost Flu Vaccine Effectiveness In Data Presented At World Vaccine Congress 4/9/2015 10:49:15 AM
Kineta Inc.’s Novel Antiviral Compounds Inhibit Broad Array Of Emerging And Current Viruses Including Ebola 3/26/2015 9:06:22 AM
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015 10:23:49 AM
Kineta Inc. Completes Enrollment Of First Psoriasis Clinical Trial Using Novel ShK-186 1/21/2015 10:51:27 AM
Kineta Inc. Announces The Opening Of The First Psoriasis Clinical Trial Using Novel ShK-186 10/14/2014 8:27:27 AM
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014 7:56:44 AM